Encompass Health Corporation EHC 深 滬
已收盤 01-30 16:00:00 美东时间
94.53
-0.050
-0.05%
華盛通- 最 高95.00
- 今 開94.14
- 成交量 103.66万股
- 最 低 93.37
- 昨 收 94.58
- 總市值 95.48亿
- 52周最高 127.80
- 市盈率 靜 21.20
- 換手率 1.03%
- 52周最低 91.81
- 委 比 -47.06%
- 總股本 1.01亿
- 歷史最高 127.80
- 量 比 0.83
- 振 幅 1.72%
- 歷史最低 30.485
- 每 手 1
- 風險率 9.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Hospitals Face Profit Squeeze As Policy Risks Grow: Analyst
BofA warns hospitals face profit and volume pressure from policy cuts, favors post-acute care, upgrades Brookdale, and sees select names better positioned to weather challenges.
01-08 04:17
Encompass Health Reaffirms Full-Year 2025 Guidance; Net Operating Revenue Of $5.905B-$5.955B; Adjusted EBITDA Of $1.235B-$1.255B; Adjusted EPS From Continuing Operations Attributable To Encompass Health Of $5.22-$5.37
Members of Encompass Health Corporation's (the "Company" or "Encompass Health") senior management team are scheduled to meet with investors and analysts at various meetings on December 2, 2025 and December 3, 2025.The
2025-12-02 05:55
How Do Investors Really Feel About Encompass Health Corp?
Encompass Health Corp's (NYSE:EHC) short interest as a percent of float has ris...
2025-11-18 00:00
Rehabilitation Hospital of Amarillo now open in Texas
The 50-bed inpatient rehabilitation hospital is a joint venture between Encompass Health and BSA Health System. BIRMINGHAM, Ala. and AMARILLO, Texas, Nov. 10, 2025 /PRNewswire/ -- Today, Enc...
2025-11-11 05:34
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
2025-10-31 10:25
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $150
Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $141 to $150.
2025-10-31 00:03
Encompass Health Raises FY2025 Adj EPS Guidance from $5.12-$5.34 to $5.22-$5.37 vs $5.28 Est; Narrows FY2025 Sales Guidance from $5.880B-$5.980B to $5.905B-$5.955B vs $5.935B Est
Encompass Health (NYSE:EHC) raises FY2025 Adj EPS guidance from $5.12-$5.34 to $5.22-$5.37 vs $5.28 analyst estimate. Narrows FY2025 sales outlook from $5.880 billion-$5.980 billion to $5.905 billion-$5.955 billion vs
2025-10-30 04:23
Encompass Health declares $0.19 dividend
Encompass Health (NYSE:EHC) declares $0.19/share quarterly dividend, in line with previous. Forward yield 0.6% Payable Jan. 15; for shareholders of record Jan. 2; ex-div Jan. 2. See EHC Dividend Score...
2025-10-23 22:52
Encompass Health declares dividend on common stock
BIRMINGHAM, Ala., Oct. 23, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $...
2025-10-23 21:48
